Dr Elaine Ferguson
Projects as PI
- Accumulation and nephrotoxicity of dextin-colistin conjugates (02/08/2016 - 30/09/2021)
- Biorespondive polymer-peptide conjugates as novel antibacterial agents (01/04/2010 - 31/03/2011)
- Developing circadian enzyme-controlled polymer therapeutics (01/04/2022 - 31/03/2025)
- Development of a method for physiochemical analysis of released saccharides from polysaccharide-peptide conjugates (05/09/2018 - 04/10/2019)
- Development of a nanomedicine approach to achieve simultaneous targeting of cancer and bacterial infections (19/11/2018 - 31/12/2020)
Projects as Co-Investigator
- Core Equipment Grant (02/01/2023 - 01/07/2024)
- Development of a nanomedicine approach to reduce the unacceptable side effects of bexarotene (15/05/2022 - 14/09/2022)
- Novel alginate oligomer products for enhanced pharmaceutical delivery across mucosal barrier (Mucos-ALG) (24/09/2018 - 31/07/2023)
- Re-purposing dextrin-colistin conjugates to prevent aberrant inflammation in osteoarthritis (27/11/2023 - 26/05/2024)